| P50 | author | Mauro Biffoni | Q37391458 |
| | Maria Musumeci | Q42843538 |
| | Désirée Bonci | Q43132273 |
| | Ruggero De Maria | Q64679020 |
| P2093 | author name string | Cesare Peschle | |
| | Lorenzo Memeo | |
| | Catherine Labbaye | |
| | Valeria Coppola | |
| | Leonardo D'Urso | |
| | Giovanni Muto | |
| | Monica Bartucci | |
| | Raffaella Giuffrida | |
| | Alfredo Pagliuca | |
| | Antonio Addario | |
| P2860 | cites work | Human MicroRNA targets | Q21563637 |
| | miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 |
| | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| | Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 |
| | Prediction of mammalian microRNA targets | Q27860498 |
| | Combinatorial microRNA target predictions | Q27860510 |
| | Oncomirs - microRNAs with a role in cancer | Q27860773 |
| | Wnt/beta-catenin signaling in development and disease | Q27860784 |
| | Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 |
| | Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 |
| | MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 |
| | Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer | Q28211530 |
| | A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 |
| | Cancer cell cycles | Q29547756 |
| | Cancer statistics, 2006 | Q29615133 |
| | MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 |
| | MicroRNA-133 controls cardiac hypertrophy | Q29616572 |
| | Delineation of prognostic biomarkers in prostate cancer | Q29617971 |
| | MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation | Q34212635 |
| | Advances in prostate cancer chemotherapy: a new era begins. | Q36258531 |
| | Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype | Q36309713 |
| | Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. | Q38319485 |
| | RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain | Q38439681 |
| | 'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. | Q40655750 |
| | Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization | Q41065941 |
| | Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. | Q41107142 |
| | Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation | Q42472178 |
| | Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences | Q44491759 |
| | A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer | Q46493707 |
| | RNAi-mediated gene silencing in non-human primates. | Q53630565 |
| | Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. | Q73283461 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 1271-7 | |
| P577 | publication date | 2008-11-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | |
| P478 | volume | 14 | |